These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29088364)

  • 21. Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low-Risk Population With Type 2 Diabetes Mellitus.
    Malmborg M; Schmiegelow MDS; Gerds T; Schou M; Kistorp C; Torp-Pedersen C; Gislason G
    J Am Heart Assoc; 2021 Jul; 10(13):e020395. PubMed ID: 34151606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes with high-intensity statins according to atherothrombotic risk stratification after acute myocardial infarction: The FAST-MI registries.
    Desjobert E; Tea V; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2021 Feb; 114(2):88-95. PubMed ID: 33011156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in Statin Use 2009-2015 in a Large Integrated Health System: Pre- and Post-2013 ACC/AHA Guideline on Treatment of Blood Cholesterol.
    Harrison TN; Scott RD; Cheetham TC; Chang SC; Hsu JY; Wei R; Ling Grant DS; Boklage SH; Romo-LeTourneau V; Reynolds K
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):397-404. PubMed ID: 30062465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 10-Year Trend in Statin Use Among Older Adults in Australia: an Analysis Using National Pharmacy Claims Data.
    Ofori-Asenso R; Ilomäki J; Zomer E; Curtis AJ; Zoungas S; Liew D
    Cardiovasc Drugs Ther; 2018 Jun; 32(3):265-272. PubMed ID: 29790056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD.
    Mahtta D; Ahmed ST; Ramsey DJ; Akeroyd JM; Lee MT; Rodriguez F; Michos ED; Itchhaporia D; Nasir K; Alam M; Jneid H; Ballantyne CM; Petersen LA; Virani SS
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):745-754. PubMed ID: 32840709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database.
    Vinogradova Y; Coupland C; Brindle P; Hippisley-Cox J
    BMJ; 2016 Jun; 353():i3305. PubMed ID: 27353261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Statin Therapy and Dose on Cardiovascular and Limb Outcomes in Peripheral Arterial Disease: A Systematic Review and Meta-analysis.
    Sofat S; Chen X; Chowdhury MM; Coughlin PA
    Eur J Vasc Endovasc Surg; 2021 Sep; 62(3):450-461. PubMed ID: 34389230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Under-prescription of statins in patients with non-alcoholic fatty liver disease.
    Del Ben M; Baratta F; Polimeni L; Pastori D; Loffredo L; Averna M; Violi F; Angelico F
    Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):161-167. PubMed ID: 27914698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France.
    Giral P; Neumann A; Weill A; Coste J
    Eur Heart J; 2019 Nov; 40(43):3516-3525. PubMed ID: 31362307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.
    Arca M; Ansell D; Averna M; Fanelli F; Gorcyca K; Iorga ŞR; Maggioni AP; Paizis G; Tomic R; Catapano AL
    Atherosclerosis; 2018 Apr; 271():120-127. PubMed ID: 29499359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular risk profile and use of statins at the age of 70 years: a comparison of two Finnish birth cohorts born 20 years apart.
    Upmeier E; Vire J; Korhonen MJ; Isoaho H; Lehtonen A; Arve S; Wuorela M; Viitanen M
    Age Ageing; 2016 Jan; 45(1):84-90. PubMed ID: 26764397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
    März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D
    Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid Testing and Statin Dosing After Acute Myocardial Infarction.
    Wang WT; Hellkamp A; Doll JA; Thomas L; Navar AM; Fonarow GC; Julien HM; Peterson ED; Wang TY
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29371200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study.
    Hamoui O; Omar MI; Raal FJ; Rashed W; Kane A; Alami M; Abreu P; Mashhoud W; Alsheikh-Ali AA
    BMC Cardiovasc Disord; 2019 Mar; 19(1):61. PubMed ID: 30876390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study.
    Waheed S; Pollack S; Roth M; Reichek N; Guerci A; Cao JJ
    Atherosclerosis; 2016 Dec; 255():193-199. PubMed ID: 27693004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins and Elderly: From Clinical Trials to Daily Practice.
    Verdoia M; Galasso G; Filardi PP; De Luca G
    Curr Vasc Pharmacol; 2019; 17(3):233-238. PubMed ID: 29956633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in statin prescription prevalence, initiation, and dosing: Hong Kong, 2004-2015.
    Blais JE; Chan EW; Law SWY; Mok MT; Huang D; Wong ICK; Siu CW
    Atherosclerosis; 2019 Jan; 280():174-182. PubMed ID: 30529830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication Discontinuation in the IMPROVE-IT Trial.
    Navar AM; Roe MT; White JA; Cannon CP; Lokhnygina Y; Newby LK; Giugliano RP; Tershakovec AM; Braunwald E; Califf RM; Blazing MA
    Circ Cardiovasc Qual Outcomes; 2019 Jan; 12(1):e005041. PubMed ID: 30630361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study.
    Na E; Cho S; Kim DJ; Choi J; Han E
    Cardiovasc Diabetol; 2020 May; 19(1):67. PubMed ID: 32416728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.